Rathbones Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Hold |
|
|||||
|
2025
Q1 | $316K | Hold |
|
|||||
|
2024
Q4 | $276K | Hold |
|
|||||
|
2024
Q3 | $334K | Hold |
|
|||||
|
2024
Q2 | $315K | Hold |
|
|||||
|
2024
Q1 | $351K | Sell |
|
|||||
|
2023
Q4 | $330K | Hold |
|
|||||
|
2023
Q3 | $323K | Buy |
|
|||||
|
2023
Q2 | $280K | Hold |
|
|||||
|
2023
Q1 | $280K | Hold |
|
|||||
|
2022
Q4 | $276K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $208K | Sell |
|
|||||
|
2020
Q4 | $247K | Hold |
|
|||||
|
2020
Q3 | $253K | Hold |
|
|||||
|
2020
Q2 | $274K | Sell |
|
|||||
|
2020
Q1 | $261K | Hold |
|
|||||
|
2019
Q4 | $323K | Hold |
|
|||||
|
2019
Q3 | $293K | Hold |
|
|||||
|
2019
Q2 | $275K | Hold |
|
|||||
|
2019
Q1 | $287K | Hold |
|
|||||
|
2018
Q4 | $263K | Hold |
|
|||||
|
2018
Q3 | $276K | Hold |
|
|||||
|
2018
Q2 | $277K | Hold |
|
|||||
|
2018
Q1 | $269K | Sell |
|
|||||
|
2017
Q4 | $272K | Sell |
|
|||||
|
2017
Q3 | $381K | Hold |
|
|||||
|
2017
Q2 | $404K | Hold |
|
|||||
|
2017
Q1 | $395K | Sell |
|
|||||
|
2016
Q4 | $455K | Buy |
|
|||||
|
2016
Q3 | $381K | Hold |
|
|||||
|
2016
Q2 | $383K | Hold |
|
|||||
|
2016
Q1 | $358K | Sell |
|
|||||
|
2015
Q4 | $369K | Hold |
|
|||||
|
2015
Q3 | $352K | Hold |
|
|||||
|
2015
Q2 | $382K | Hold |
|
|||||
|
2015
Q1 | $423K | Sell |
|
|||||
|
2014
Q4 | $545K | Sell |
|
|||||
|
2014
Q3 | $604K | Buy |
|
|||||
|
2014
Q2 | $687K | Buy |
|
|||||
|
2014
Q1 | $624K | Buy |
|
|||||
|
2013
Q4 | $548K | Sell |
|
|||||
|
2013
Q3 | $628K | Hold |
|
|||||
|
2013
Q2 | $625K | Buy |
|